According to Gland Pharma 's latest financial reports the company's current EPS (TTM) is โน47.27. In 2022 the company made an earnings per share (EPS) of โน64.77 a decrease over its 2021 EPS that were of โน83.61.
Year | EPS | Change |
---|---|---|
2023 (TTM) | โน45.29 | -30.08% |
2022 | โน64.77 | -22.53% |
2021 | โน83.61 | 26.92% |
2020 | โน65.88 |